Baillie Gifford & Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-499,889
| Closed | -$4.97M | – | 488 |
|
|
2022
Q3 | $4.97M | Buy |
499,889
+15,412
| +3% | +$153K | 0.01% | 237 |
|
|
2022
Q2 | $4.4M | Sell |
484,477
-57,414
| -11% | -$521K | ﹤0.01% | 241 |
|
|
2022
Q1 | $5.5M | Buy |
541,891
+52,170
| +11% | +$530K | ﹤0.01% | 250 |
|
|
2021
Q4 | $8.17M | Buy |
489,721
+23,845
| +5% | +$398K | ﹤0.01% | 252 |
|
|
2021
Q3 | $21.8M | Buy |
465,876
+45,984
| +11% | +$2.16M | 0.01% | 220 |
|
|
2021
Q2 | $25.6M | Buy |
419,892
+107,247
| +34% | +$6.54M | 0.01% | 218 |
|
|
2021
Q1 | $19.3M | Buy |
312,645
+194,113
| +164% | +$12M | 0.01% | 227 |
|
|
2020
Q4 | $8.43M | Buy |
118,532
+58,063
| +96% | +$4.13M | ﹤0.01% | 224 |
|
|
2020
Q3 | $2.27M | Buy |
60,469
+54,660
| +941% | +$2.05M | ﹤0.01% | 230 |
|
|
2020
Q2 | $189K | Buy |
5,809
+3,109
| +115% | +$101K | ﹤0.01% | 237 |
|
|
2020
Q1 | $78K | Buy |
+2,700
| New | +$78K | ﹤0.01% | 220 |
|